The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2020

Filed:

Nov. 24, 2015
Applicant:

Curadigm Sas, Paris, FR;

Inventors:

Matthieu Germain, Champigny sur Marne, FR;

Marie-Edith Meyre, Saint Mande, FR;

Agnes Pottier, Paris, FR;

Laurent Levy, Paris, FR;

Assignee:

CURADIGM SAS, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 47/69 (2017.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01); A61K 9/51 (2006.01); A61K 31/704 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1271 (2013.01); A61K 9/127 (2013.01); A61K 9/51 (2013.01); A61K 31/704 (2013.01); A61K 47/6911 (2017.08); A61K 9/0009 (2013.01); A61K 9/0019 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition comprising the combination of (i) at least one biocompatible nanoparticle and (ii) at least one carrier comprising at least one pharmaceutical compound, to be administered to a subject in need of such a pharmaceutical compound, wherein the combination of the at least one biocompatible nanoparticle and of the at least one carrier comprising the pharmaceutical compound(s) potentiates the compound(s) of interest effectiveness in therapy, prophylaxis or diagnosis. The invention also relates to such a composition for use for administering the pharmaceutical compound(s) in a subject in need thereof, wherein the at least one biocompatible nanoparticle and the at least one carrier comprising the at least one pharmaceutical compound are to be administered separately in a subject in need of said pharmaceutical compound, typically between more than 5 minutes and about 72 hours one from each other.


Find Patent Forward Citations

Loading…